i.beaulieu
TL2 Moderator · Recife
Contributes reviews on supplier material. Based in Recife.
Joined 11 March 2025 · last posted 2d
84Posts here
0Topics
3Solutions
1.2kLikes received
1.2kLikes given
21Badges
222Days visited
4.8kPosts read
Recent activity
Full stream-
Coming back to: Time to steady state after a dose increase Replied, post #111 · Pharmacology › Pharmacokinetics · 26 Jul 2026 · 15 likes Accumulation at steady state: with a week-long half-life, steady-state concentration is reached around 4 to 5 half-lives (about 4 to 5 weeks). Before that,…
-
Follow-up: Reading an interaction checker output critically Replied, post #47 · Practice › Interactions · 15 Jul 2026 · 0 likes SGLT2 inhibitors: frequently co-administered and relevant to renal and cardiovascular discussion, not to interactions. There is no pharmacokinetic interaction of concern.
-
Osteoarthritis and mechanical versus metabolic improvement — one year on Replied, post #55 · Clinical › Comorbidities · 13 Jul 2026 · 5 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
Why pulsatile secretion matters for interpreting secretagogue claims Replied, post #6 · Compounds › Secretagogues & GH axis · 12 Jul 2026 · 0 likes IGF-1 as a surrogate: it is a better integrated measure than a spot growth hormone level and it is still a surrogate, with all the caveats that come with surrogates.…
-
Angle of injection and whether 90 degrees is always right — the long version Replied, post #42 · Practice › Administration · 9 Jul 2026 · 0 likes Picking up post #39: that is the part I would want checked first. Injecting into an area that has become firm: lipohypertrophy — thickened fatty tissue from repeated…
-
Private prescribing in the UK: what is actually involved Replied, post #57 · Regional › UK & Ireland · 6 Jul 2026 · 6 likes Supply and shortage resilience: both UK and Ireland sourced primarily from European suppliers until recent disruptions. Domestic availability and pricing changed.
-
Muscle cramps: the ordinary causes before the exotic ones — a second dataset Replied, post #31 · Practice › Side effects · 5 Jul 2026 · 17 likes On post #27 — agreed on the reasoning, with one qualification. Nausea: the most common side effect and the most dose- and titration-dependent one. It is usually most…
-
[2026 update] Travelling with an injectable: documentation and practicalities Replied, post #56 · Access › International · 4 Jul 2026 · 17 likes Country-by-country legality: compound approval and legal status differ substantially by jurisdiction. Semaglutide approved in the United States and European Union;…
-
What published stability data actually covers, and what it does not Replied, post #9 · marked as the solution · Practice › Storage & stability · 3 Jul 2026 · 7 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
Journal club: LEADER as the historical anchor Replied, post #97 · Evidence › Journal club · 30 Jun 2026 · 2 likes TRIUMPH (ongoing): Retatrutide phase 3. No results yet. Nothing should be attributed to it because it has not finished. When it does, this discussion will return to it.
-
Asking a follow-up: new topic or new reply? Replied, post #31 · Start Here › How to Ask · 30 Jun 2026 · 14 likes Avoid "any advice?" at the end. It is so generic that people do not know which part of the post it refers to. Pick the specific part and ask that specific question…
-
Reflectance and photometric devices: precision in practice — a second dataset Replied, post #61 · Analytics › Home & field testing · 30 Jun 2026 · 2 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…